Zydus receives EIR for oncology injectable manufacturing facility in Ahmedabad SEZ1
The facility has been classified as Voluntary Action Indicated
The facility has been classified as Voluntary Action Indicated
Sessions will cover process mapping, cost optimisation, data-driven decision-making, cybersecurity, and sustainable manufacturing practices
The inspection concluded with zero form 483 observations
Pete Pharma will leverage FABRX’s extensive foundation of scientific validation to deliver a commercially viable, pharmacy-ready solution in the US
Maria Soler Nunez appointed as Chief Quality Officer
The Ma’anshan site approval covers pastilles, oral liquids, and powders
Goyal reaffirmed the government’s commitment to facilitating market access, reducing trade barriers, and ensuring that Indian exporters remain globally competitive
The U.S. FDA issued a Form 483 with five observations
Subscribe To Our Newsletter & Stay Updated